Myriad Genetics Inc
(MYGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2011 | 06-2010 | 06-2009 | 06-2008 | 06-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 52,681 | 92,840 | 63,510 | 237,734 | 143,432 |
| Marketable Securities | 293,776 | 310,388 | 253,345 | 90,994 | 70,679 |
| Receivables | 50,847 | 48,134 | 44,617 | 45,432 | 32,451 |
| Inventories | 8,218 | N/A | N/A | N/A | N/A |
| Income taxes - deferred | 9,790 | 18,560 | N/A | N/A | N/A |
| Other current assets | 0 | 0 | 655 | 0 | 0 |
| TOTAL | $418,261 | $473,976 | $366,120 | $377,303 | $252,534 |
| Non-Current Assets | |||||
| PPE Net | 23,080 | 23,261 | 22,623 | 30,026 | 24,888 |
| Investments And Advances | 70,857 | 85,154 | 75,370 | 91,328 | 94,201 |
| Intangibles | 72,766 | 2,052 | 0 | 0 | 0 |
| Other Non-Current Assets | 25,863 | 9,404 | 2,275 | 685 | 3,917 |
| TOTAL | $192,566 | $119,871 | $100,268 | $122,039 | $123,006 |
| Total Assets | $610,827 | $593,847 | $466,388 | $499,342 | $375,540 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,395 | 8,870 | 14,177 | 24,884 | 15,763 |
| Accrued Expenses | 21,645 | 18,596 | 17,992 | 46,770 | 19,031 |
| TOTAL | $34,387 | $27,466 | $32,169 | $73,687 | $35,177 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,347 | 0 | N/A | 2,033 | 383 |
| Other Non-Current Liabilities | 9,648 | 8,800 | 0 | 0 | 0 |
| TOTAL | $9,648 | $8,800 | $N/A | $N/A | $N/A |
| Total Liabilities | $44,035 | $36,266 | $32,169 | $73,687 | $35,177 |
| Shareholders' Equity | |||||
| Common Shares | 862 | 940 | 959 | 894 | 434 |
| Retained earnings | -38,630 | -10,465 | -119,940 | -204,555 | -252,400 |
| Other shareholders' equity | 151 | 139 | 2,768 | -237 | -398 |
| TOTAL | $566,792 | $557,581 | $434,219 | $425,655 | $340,363 |
| Total Liabilities And Equity | $610,827 | $593,847 | $466,388 | $499,342 | $375,540 |